These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 9410074)

  • 41. [Pharmacoeconomics of meropenem versus imipenem/cilastatin].
    Marquina MC; Giráldez J; Idoate A
    Enferm Infecc Microbiol Clin; 1997 Sep; 15 Suppl 1():45-50. PubMed ID: 9410069
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Meropenem monotherapy is as effective as and safer than imipenem to treat brain abscesses.
    Martin-Canal G; Saavedra A; Asensi JM; Suarez-Zarracina T; Rodriguez-Guardado A; Bustillo E; Fierer J; Carton JA; Collazos J; Asensi V
    Int J Antimicrob Agents; 2010 Mar; 35(3):301-4. PubMed ID: 20045289
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Review of adverse experiences and tolerability in the first 2,516 patients treated with imipenem/cilastatin.
    Calandra GB; Brown KR; Grad LC; Ahonkhai VI; Wang C; Aziz MA
    Am J Med; 1985 Jun; 78(6A):73-8. PubMed ID: 3859218
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Report of eight cases of pulmonary actinomycosis and their treatment with imipenem-cilastatin.
    Yew WW; Wong PC; Lee J; Fung SL; Wong CF; Chan CY
    Monaldi Arch Chest Dis; 1999 Apr; 54(2):126-9. PubMed ID: 10394825
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Intramuscular imipenem/cilastatin in the treatment of mild and moderate infections.
    Wang C; Pappas F; Cook T
    Scand J Infect Dis Suppl; 1987; 52():32-9. PubMed ID: 3331041
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparative evaluation of intratracheal colistimethate sodium, imipenem, and meropenem in BALB/c mice with carbapenem-resistant Acinetobacter baumannii pneumonia.
    Tang HJ; Chuang YC; Ko WC; Chen CC; Shieh JM; Chen CH; Lee NY; Chiang SR
    Int J Infect Dis; 2012 Jan; 16(1):e34-40. PubMed ID: 22088863
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Investigation on administration method of carbapenems].
    Mikamo H; Ninomiya M; Tamaya T
    Jpn J Antibiot; 2002 Dec; 55(6):875-81. PubMed ID: 12621741
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Imipenem/cilastatin: evolution of the sustained-release intramuscular formulation.
    Kahan FM; Rogers JD
    Chemotherapy; 1991; 37 Suppl 2():21-5. PubMed ID: 1879183
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A post hoc subgroup analysis of meropenem versus imipenem/cilastatin in a multicenter, double-blind, randomized study of complicated skin and skin-structure infections in patients with diabetes mellitus.
    Embil JM; Soto NE; Melnick DA
    Clin Ther; 2006 Aug; 28(8):1164-1174. PubMed ID: 16982293
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pharmacodynamic modeling of imipenem-cilastatin, meropenem, and piperacillin-tazobactam for empiric therapy of skin and soft tissue infections: a report from the OPTAMA Program.
    Ong CT; Kuti JL; Nicolau DP;
    Surg Infect (Larchmt); 2005; 6(4):419-26. PubMed ID: 16433606
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Biapenem versus imipenem/cilastatin in the treatment of complicated intra-abdominal infections: report from a Swedish Study Group.
    Brismar B; Akerlund JE; Sjöstedt S; Johansson C; Törnqvist A; Bäckstrand B; Bång H; Andåker L; Gustafsson PO; Darle N; Angerås M; Falk A; Tunevall G; Kasholm-Tengve B; Skau T; Nyström PO; Gasslander T; Hagelbäck A; Olsson-Liljequist B; Eklund AE; Nord CE
    Scand J Infect Dis; 1996; 28(5):507-12. PubMed ID: 8953683
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Intramuscular imipenem/cilastatin for treatment of mild and moderately severe bacterial infections.
    Keller CA; Villavicencio J; Ramirez C
    Scand J Infect Dis Suppl; 1987; 52():26-31. PubMed ID: 3483287
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Drug utilization evaluation of imipenem/cilastatin in patients with renal dysfunction.
    Sheakely ML; Nicolau DP; Agner SI
    Ann Pharmacother; 1993; 27(7-8):981-2. PubMed ID: 8364293
    [No Abstract]   [Full Text] [Related]  

  • 54. Comparative neurotoxicity of benzylpenicillin, imipenem/cilastatin and FCE 22101, a new injectible penem.
    Schliamser SE; Broholm KA; Liljedahl AL; Norrby SR
    J Antimicrob Chemother; 1988 Nov; 22(5):687-95. PubMed ID: 3209527
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [A randomized, controlled clinical trial of meropenem and imipenem/cilastatin in the treatment of acute bacterial infections].
    Hou F; Wu G; Zheng B
    Zhonghua Nei Ke Za Zhi; 2001 Sep; 40(9):589-93. PubMed ID: 11758237
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Vertigo caused by intravenous imipenem/cilastatin.
    Duque A; Altimiras J; García-Cases C; Vidal P
    DICP; 1991 Sep; 25(9):1009. PubMed ID: 1949961
    [No Abstract]   [Full Text] [Related]  

  • 57. Cholangiopathy after short-term administration of piperacillin and imipenem/cilastatin.
    Quattropani C; Schneider M; Helbling A; Zimmermann A; Krähenbühl S
    Liver; 2001 Jun; 21(3):213-6. PubMed ID: 11422785
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A multicenter, randomized controlled clinical study on biapenem and imipenem/cilastatin injection in the treatment of respiratory and urinary tract infections.
    Jia B; Lu P; Huang W; Li C; Huang A; Zhou X; Zhang W; Wu G; Zhang G
    Chemotherapy; 2010; 56(4):285-90. PubMed ID: 20714145
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Meropenem: an updated review of its use in the management of intra-abdominal infections.
    Lowe MN; Lamb HM
    Drugs; 2000 Sep; 60(3):619-46. PubMed ID: 11030471
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The effects of phenytoin and phenobarbital on seizures induced by imipenem/cilastatin in rats.
    Zivanovic D; Stanojlovic O; Susic V; Stojanovic J
    Acta Neurol Belg; 2004 Mar; 104(1):20-6. PubMed ID: 15143958
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.